Literature DB >> 6755202

Potential life-threatening variations of drug concentrations in intravenous infusion systems: potassium chloride, insulin, and heparin.

N Bergman, I D Vellar.   

Abstract

The investigation of concentrations of active agents in common carrier media for intravenous infusion revealed that potassium chloride tends to form a pool when it is added without mixing to carrier media in glass or polyvinyl chloride (PVC) containers which are already suspended in their functional position with ports pointing downwards. Heparin behaves in a similar fashion when added without mixing to carrier media in PVC containers. Such uneven distribution may expose a patient to potentially dangerous, possibly lethal, concentrations of a drug even when a relatively small amount of it is used. Insulin floats to the top of a Haemaccel container if its contents are not adequately mixed after addition of insulin. The resultant irregularity of insulin dosage may make the management of diabetic ketoacidosis more difficult. It is recommended that the instructions for the adequate mixing of contents should appear on all containers of carrier media for intravenous infusions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6755202

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  Validation of a procedure to mix homogenous solutions in bags and syringes.

Authors:  Thomann Pauline; Bouchoud Lucie; Bonnabry Pascal
Journal:  Eur J Hosp Pharm       Date:  2017-08-31

2.  Accuracy of potassium supplementation of fluids administered intravenously.

Authors:  S N Hoehne; K Hopper; S E Epstein
Journal:  J Vet Intern Med       Date:  2015-04-09       Impact factor: 3.333

3.  Prevalence and determinants of intravenous admixture preparation errors: A prospective observational study in a university hospital.

Authors:  Janique G Jessurun; Nicole G M Hunfeld; Joost van Rosmalen; Monique van Dijk; Patricia M L A van den Bemt
Journal:  Int J Clin Pharm       Date:  2021-08-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.